Amber Sands, PA
Physician Assistant · Reno, NVNPI 1134276389
Payments from drug & device makers
Across 44 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$210
- AbbVie$137
- Vertex$111
- Saluda Medical Americas, Inc.$100
- Averitas Pharma Inc.$82
- Medtronic$56
- plus $248 from 11 others
What the payments were for
- Food & beverage$943100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $210 |
| AbbVie(2 entities) | 7 | $137 |
| Vertex | 2 | $111 |
| Saluda Medical Americas, Inc. | 5 | $100 |
| Averitas Pharma Inc. | 2 | $82 |
| Medtronic | 3 | $56 |
| Abbott | 3 | $53 |
| SPR Therapeutics, Inc | 3 | $32 |
| Stimwave Technologies Incorporated | 1 | $27 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Relievant Medsystems, Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Nevro Corp. | 1 | $12 |
How this compares
$943 in reported general payments places this provider in the 60th percentile of 881 physician assistant providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 340 | $8,162 |
| Gabapentin | 319 | $7,440 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 231 | $5,867 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 297 | $5,837 |
| Lidocaine | 48 | $4,669 |
| Tramadol Hcl | 130 | $2,752 |
| Duloxetine Hcl | 74 | $2,682 |
| Oxycodone Hcl | 149 | $2,255 |
| Methocarbamol | 144 | $2,029 |
| Buprenorphine | 11 | $1,735 |
| Cyclobenzaprine Hcl | 184 | $1,726 |
| Tizanidine Hcl | 107 | $1,667 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 13 | $1,572 |
| Celecoxib | 64 | $1,220 |
| Baclofen | 24 | $776 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Reno
- John LarsenReno$49K
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Rebecca SparksReno$16K
- Daniel CollReno$12K
- Cameron WheelerReno$11K
- Julia WronaReno$10K
- Amber FrancoReno$9K
- Paul JohnsReno$8K
- Shannon WeaverReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.